Yuen Wo Tsang
Hoofd Techniek/Wetenschap/O&O bij WAI YUEN TONG MEDICINE HOLDINGS LIMITED
Actieve functies van Yuen Wo Tsang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
WAI YUEN TONG MEDICINE HOLDINGS LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-09-2018 | - |
Luxembourg Institute of Health
Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Yuen Wo Tsang
Opleiding van Yuen Wo Tsang
University of Aston | Undergraduate Degree |
The University of Sydney | Graduate Degree |
Statistieken
Internationaal
Hongkong | 2 |
Verenigd Koninkrijk | 2 |
Australië | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
WAI YUEN TONG MEDICINE HOLDINGS LIMITED | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Luxembourg Institute of Health
Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass. | Commercial Services |
- Beurs
- Insiders
- Yuen Wo Tsang
- Ervaring